Breast Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Female patients aged >= 18 years and <= 75 years; (2) Patients with newly diagnosed breast ultrasound BI-RADs classification of 4b or higher, highly suspected of breast cancer; (3) ECOG score of 0-2; (4) Voluntarily participate in this clinical study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Women who are pregnant or breastfeeding, or who have plans to have children during the study period; (2) Those with a history of other malignant tumors; (3) Patients with severe diseases of the heart, brain, liver, kidney, hematopoietic system, etc., liver function damage, or diabetes; (4) Patients judged by researchers to have other life-threatening diseases; (5) Those currently participating in other drug trials; (6) Unable to cooperate in completing data collection or with incomplete data. (7) The puncture result is benign.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tissue single-cell sequencing; | — |
Countries
China
Contacts
the first affiliated hospital of Guangzhou University of Chinese Medicine